Graduate School of Science and Engineering, Saitama University, 255 Shimo-Okubo, Saitama 338-8570, Japan.
Biochem Biophys Res Commun. 2012 Apr 27;421(1):129-33. doi: 10.1016/j.bbrc.2012.03.130. Epub 2012 Apr 4.
Several engineered protein scaffolds have been developed recently to circumvent particular disadvantages of antibodies such as their large size and complex composition, low stability, and high production costs. We previously identified peptide aptamers containing one or two disulfide-bonds as an alternative ligand to the interleukin-6 receptor (IL-6R). Peptide aptamers (32 amino acids in length) were screened from a random peptide library by in vitro peptide selection using the evolutionary molecular engineering method "cDNA display". In this report, the antagonistic activity of the peptide aptamers were examined by an in vitro competition enzyme-linked immunosorbent assay (ELISA) and an IL-6-dependent cell proliferation assay. The results revealed that a disulfide-rich peptide aptamer inhibited IL-6-dependent cell proliferation with similar efficacy to an anti-IL-6R monoclonal antibody.
近年来,已经开发出几种工程化蛋白质支架,以规避抗体的一些特殊缺点,例如其体积大、组成复杂、稳定性低和生产成本高。我们之前鉴定了含有一个或两个二硫键的肽适体作为白细胞介素-6 受体 (IL-6R) 的替代配体。肽适体(长度为 32 个氨基酸)是通过使用“cDNA 展示”的进化分子工程方法从随机肽文库中筛选出来的。在本报告中,通过体外竞争酶联免疫吸附测定 (ELISA) 和 IL-6 依赖性细胞增殖测定来检查肽适体的拮抗活性。结果表明,富含二硫键的肽适体抑制 IL-6 依赖性细胞增殖的效果与抗 IL-6R 单克隆抗体相似。